Centerbridge explores sale of Versant Health - sources
Share:
(Reuters) - Private equity firm Centerbridge Partners LP is exploring a sale of Versant Health in a deal which could value the U.S. managed vision care benefits company at more than $2 billion (£1.56 billion), including debt, people familiar with the matter said on Tuesday. Versant could appeal to other medical benefits providers as well as buyout firms seeking to consolidate the sector. Earlier this year, privately held VSP Global, another managed eye care benefits provider, acquired..